Bupropion Hydrochloride
- Product NDC
- 68788-7509
- 11-digit product format
- 687887509
- Labeler code
- 68788
- Product ID
- 68788-7509_0a05102a-dba8-484c-b9e2-498413879e46
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals, Inc.
- Application
- ANDA207224
- Marketing category
- ANDA
- Marketing start
- 2017-10-01
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7509-1 | 68788750901 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7509-1) | 2019-10-25 | 0000-00-00 | No | No | Current |
| 68788-7509-3 | 68788750903 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7509-3) | 2019-10-25 | 0000-00-00 | No | No | Current |
| 68788-7509-6 | 68788750906 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7509-6) | 2019-10-25 | 0000-00-00 | No | No | Current |
| 68788-7509-8 | 68788750908 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7509-8) | 2019-10-25 | 0000-00-00 | No | No | Current |
| 68788-7509-9 | 68788750909 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7509-9) | 2019-10-25 | 0000-00-00 | No | No | Current |